Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;5(5):e001042.
doi: 10.1136/esmoopen-2020-001042.

The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): a new Pandora's box?

Angela Dalia Ricci  1 , Alessandro Rizzo  2 , Giovanni Brandi  2
Affiliations
Comment

The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): a new Pandora's box?

Angela Dalia Ricci et al. ESMO Open. 2020 Sep.
No abstract available

Keywords: correspondence.

PubMed Disclaimer

Comment on

  • Molecular profile of BRCA-mutated biliary tract cancers.
    Spizzo G, Puccini A, Xiu J, Goldberg RM, Grothey A, Shields AF, Arora SP, Khushman M, Salem ME, Battaglin F, Baca Y, El-Deiry WS, Philip PA, Nassem M, Hall M, Marshall JL, Kocher F, Amann A, Wolf D, Korn WM, Lenz HJ, Seeber A. Spizzo G, et al. ESMO Open. 2020 Jun;5(3):e000682. doi: 10.1136/esmoopen-2020-000682. ESMO Open. 2020. PMID: 32576609 Free PMC article.

References

    1. Spizzo G, Puccini A, Xiu J, et al. . Molecular profile of BRCA-mutated biliary tract cancers. ESMO Open 2020;5:e000682. 10.1136/esmoopen-2020-000682 - DOI - PMC - PubMed
    1. Heeke AL, Pishvaian MJ, Lynce F, et al. . Prevalence of homologous Recombination–Related gene mutations across multiple cancer types. JCO Precis Oncol 2018;2018:1–13. - PMC - PubMed
    1. Park W, Chen J, Chou JF, et al. . Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection. Clin Cancer Res 2020;26:3239–47. 10.1158/1078-0432.CCR-20-0418 - DOI - PMC - PubMed
    1. Kim RD, Chung V, Alese OB, et al. . A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer. JAMA Oncol 2020;6:1–8. 10.1001/jamaoncol.2020.0930 - DOI - PMC - PubMed
    1. Shim JH, Kim HS, Cha H, et al. . HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients. Ann Oncol 2020;31:902–11. 10.1016/j.annonc.2020.04.004 - DOI - PubMed